Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2008
12/04/2008WO2007103365A3 Random rnai libraries, methods of generating same, and screening methods utilizing same
12/04/2008WO2007100913A3 Genes differentially expressed in bipolar disorder and/or schizophrenia
12/04/2008WO2007100618A3 Novel cell-based phosphodiesterase assays
12/04/2008WO2007095527A3 Metal-enhanced chemiluminescence (mec)
12/04/2008WO2007089862A3 Alpha-synuclein kinase
12/04/2008WO2006096269A3 Targeted gene deletions for polysaccharide slime formers
12/04/2008WO2006088904A3 Fecal sample test device and methods of use
12/04/2008WO2006073625A3 Inhibition of li expression in mammalian cells
12/04/2008US20080301837 Promoter-based gene silencing
12/04/2008US20080301832 Method for Screening Genomic Dna Fragments
12/04/2008US20080301824 Parkin interacting polypeptides and methods of use
12/04/2008US20080301821 Diagnostic and Therapeutic use of a Plasma Membrane Atpase
12/04/2008US20080300395 Using RNA interference to treat and prevent diabetes, alzheimer's, cancer disorders; antisense agents
12/04/2008US20080300384 T-bet compositions and methods of use thereof
12/04/2008US20080300263 Pyrazolo [1,5-a] pyrimidine compounds and pharmaceutical compositions containing them
12/04/2008US20080300212 Treatment and prevention of hyperproliferative conditions in humans and antisense oligonucleotide inhibition of human replication-initiation proteins
12/04/2008US20080300207 Protein production
12/04/2008US20080300206 Alpha-Synuclein Kinase
12/04/2008US20080300203 Stable Quantitation and Detection of Immune Response Levels with Non-Zero Background Peptides
12/04/2008US20080300201 Cell Cycle Arrest and Apoptosis
12/04/2008US20080300178 Method For Treating Huntington's Disease by Inhibiting Dephosphorylation of Huntingtin at S421
12/04/2008US20080300170 Compositions and methods for diagnosis and treatment for type 2 diabetes
12/04/2008US20080300167 Patched genes and uses related thereto
12/04/2008US20080300165 Purposeful Movement Of Human Migratory Cells Away From An Agent Source
12/04/2008US20080300163 Modified Human Four Helical Bundle Polypeptides And Their Uses
12/04/2008US20080300147 Detection and Treatment of Fibrotic Disorders
12/04/2008US20080300145 In vivo high throughput selection of RNAi probes
12/04/2008US20080299648 Diagnostic kit
12/04/2008US20080299618 Single domain ligands, receptors comprising said ligands, methods for their production and use of said ligands and receptors
12/04/2008US20080299604 Methods and tools for detecting collagen degradation
12/04/2008US20080299603 Predictive assay for immune response
12/04/2008US20080299602 Methods of Employing Vascular Leakage to Diagnose a Capillary Leak Disorder
12/04/2008US20080299601 Adhering Surfaces
12/04/2008US20080299600 Apparatus Assembly and Method for Detecting an Analyte
12/04/2008US20080299599 Fluorescent proteins for monitoring intracellular superoxide production
12/04/2008US20080299598 Detector Comprising a Membrane Perturbation - Detecting Polymer and Functional Membrane Fragments
12/04/2008US20080299597 Methods for assaying percentage of glycated hemoglobin
12/04/2008US20080299596 Substrates and assays for beta-secretase activity
12/04/2008US20080299595 Tailored glycoproteomic methods for the sequencing, mapping and identification of cellular glycoproteins
12/04/2008US20080299594 Proteomic analysis of biological fluids
12/04/2008US20080299593 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
12/04/2008US20080299592 Red-Shifted Luciferase
12/04/2008US20080299591 Identification of Porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
12/04/2008US20080299590 SHC protein-related methods and compositions
12/04/2008US20080299589 Methods and Materials for Examining the P13k/Akt Pathway in Gliomas and Prostate Cancers
12/04/2008US20080299587 Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists
12/04/2008US20080299583 Method and system for analyzing reactions using an information system
12/04/2008US20080299582 Culture System for Rapid Expansion of Human Embryonic Stem Cells
12/04/2008US20080299581 Screening for expressible transfectants in a eukaryotic system
12/04/2008US20080299580 Targeted integration into the PPP1R12C locus
12/04/2008US20080299579 Novel cancer marker and use thereof
12/04/2008US20080299578 Probe, probe set, probe carrier, and testing method
12/04/2008US20080299577 Probe, probe set, probe carrier, and testing method
12/04/2008US20080299576 Probe, probe set, probe carrier, and testing method
12/04/2008US20080299575 Probe, probe set, probe carrier, and testing method
12/04/2008US20080299574 Probe, probe set, probe carrier, and testing method
12/04/2008US20080299573 Probe, probe set, probe carrier, and testing method
12/04/2008US20080299572 Probe, probe set, probe carrier, and testing method
12/04/2008US20080299571 for detecting a nucleic acid of Candida kefyr which is a pathogenic fungus with a high degree of accuracy even for an analyte containing DNAs of a plurality of fungi with a less cross-contamination level
12/04/2008US20080299570 Probe, probe set, probe carrier, and testing method
12/04/2008US20080299569 Probe, probe set, probe carrier, and testing method
12/04/2008US20080299568 Materials and methods for detection of hepatitis c virus
12/04/2008US20080299567 Primer and probe sequences for detecting chlamydia trachomatis
12/04/2008US20080299566 Methylation of Gene Promoters as a Predictor of Effectiveness of Therapy
12/04/2008US20080299565 complementary hybridization; fluorophores; semiconductors
12/04/2008US20080299564 Control of Preservation By Biomarkers
12/04/2008US20080299563 Human map2 gene promoter
12/04/2008US20080299562 Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
12/04/2008US20080299561 Novel therapeutic targets in cancer
12/04/2008US20080299560 Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
12/04/2008US20080299559 Methods for authenticating articles with optical reporters
12/04/2008US20080299558 Method for detecting nucleic acid
12/04/2008US20080299557 Sample Lysis and Coating of Reaction Surface
12/04/2008US20080299556 Alkylguanyltransferase Assays
12/04/2008US20080299555 Multicolor chromogenic detection of biomarkers
12/04/2008US20080299554 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
12/04/2008US20080299553 Oligonucleotide Probes for the Genomic Typifying of Erythrocyte Systems, Methods and Relative Diagnostic Kits
12/04/2008US20080299552 Method For Determining The Function Of Nucleic Acid Sequences And Expression Products Coded Thereby
12/04/2008US20080299551 Methylation of estrogen receptor alpha and uses thereof
12/04/2008US20080299550 Methods and Kits For the Prediction of Therapeutic Success and Recurrence Free Survival In Cancer Therapy
12/04/2008US20080299549 generating a signal indicative of the presence of a target nucleic acid sequence in a sample comprise forming a cleavage structure by incubating the sample with upstream and downstream oligonucleotides, cleaving the cleavage structure with a nuclease to generate a signal
12/04/2008US20080299548 polynucleotide having a homology of 95% or more with the polynucleotide specifically expressed in a mouse embryonic stem (ES) cell; used for the detection of an ES cell, screening for a somatic cell nuclear reprogramming substance, screening for a ES cell maintaining substance
12/04/2008US20080299547 Novel stra6 polypeptides
12/04/2008US20080299546 Canine Cd20 Gene
12/04/2008US20080299545 Chromatographic methods for assessing adenovirus purity
12/04/2008US20080299544 Hcv Multiple Epitope Fusion Antigens With Modified Proteolytic Cleavage Sites And Uses Thereof
12/04/2008US20080299543 Method for Assessing Trace Element Related Disorders in Blood Plasma
12/04/2008US20080299542 Identification of oxidatively modified peptide sequences in the proteome (loscalzo)
12/04/2008US20080299541 Method and apparatus for measuring enzymatic activity by use of laser
12/04/2008US20080299540 Hormone responsive tissue culture system and uses thereof
12/04/2008US20080299539 Parallel integrated bioreactor device and method
12/04/2008US20080299537 Apparatus and Methods For Selecting Capacitated Spermatozoa and Uses Thereof
12/04/2008US20080299270 Fat Taste Receptors and Their Methods of Use
12/04/2008US20080299229 Methods of reducing beta-amyloid polypeptides
12/04/2008US20080299201 Devices, methods, and systems for accessing native neurons through artificial neural mediators (anms)
12/04/2008US20080299184 diagnosing nonsmall cell lung cancer by analyzing PCDH20 gene in a lung sample; measurement of the expression level of the cancer-suppressing gene and methylation of genomic DNA
12/04/2008US20080299153 B. anthracis prevention and treatment: mutant b. anthracis lacking luxs activity and furanone inhibition of growth, ai-2 quorum sensing, and toxin production
12/04/2008US20080299142 Compounds and methods for treatment and diagnosis of chlamydial infection
12/04/2008US20080299133 Anti-Il-12 Antibody Based Vectors, Host Cells, and Methods of Production and Uses
12/04/2008US20080299125 Genetic basis of treatment response in depression patients
1 ... 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 ... 3003